HGERS
CLSD

Householder Group Estate & Retirement Specialist’s Clearside Biomedical CLSD Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26
Closed -$589 – 1219
2024
Q1 		$589 Hold
26
– – ﹤0.01% 1147
2023
Q4 		$0 Buy
+26
New +$371 ﹤0.01% 1165

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's CLSD Position: Q2 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Clearside Biomedical (CLSD) in Q2 2024, closing a stake of 26 shares — an estimated $589 sold.

Householder Group Estate & Retirement Specialist first reported a position in CLSD in Q4 2023 and held it in 2 quarters. The position peaked at $589 in Q1 2024. 47 funds tracked by Wall St. Rank hold CLSD as of Q2 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining Clearside Biomedical position as of Q2 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 26 Clearside Biomedical shares in Q2 2024, an estimated $589.
  • Householder Group Estate & Retirement Specialist first reported a position in Clearside Biomedical in Q4 2023 and held it in 2 quarters.
  • Householder Group Estate & Retirement Specialist's Clearside Biomedical position peaked at $589 in Q1 2024.
  • 47 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q2 2024, filed 17 Jul 2024.